QuidelOrtho Corp — Director's Dealing 2022

Jun 1, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: QuidelOrtho Corp (QDEL)
CIK: 0001906324
Period of Report: 2022-05-27

Reporting Person: RHOADS ANN D (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-05-27	Common Stock	A	2248	—	Acquired	2248	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-05-27	Restricted Stock Units	$	A	427	Acquired		Common Stock (427)	Direct
2022-05-27	Restricted Stock Units	$	A	128	Acquired		Common Stock (128)	Direct

Footnotes

F1: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement was exchanged for one share of common stock of QuidelOrtho.

F2: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.

F3: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F4: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.